Serum levels of soluble programmed cell death ligand 1 as a prognostic factor on the first-line treatment of metastatic or recurrent gastric cancer
Crossref DOI link: https://doi.org/10.1007/s00432-016-2184-6
Published Online: 2016-06-02
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Takahashi, Naoki
Iwasa, Satoru
Sasaki, Yusuke
Shoji, Hirokazu
Honma, Yoshitaka
Takashima, Atsuo
Okita, Natsuko Tsuda
Kato, Ken
Hamaguchi, Tetsuya
Yamada, Yasuhide
License valid from 2016-06-02